Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2006 (Lemborexant) Phase 2 Dose Response in Chronic Insomnia
NCT01995838Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lemborexant in Insomnia, sponsored by Eisai Co., Ltd.. Started Nov 2013; status: completed.
02
Drugs
lemborexant
03
Conditions
Insomnia
Beyond the preview
Go deeper on NCT01995838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01995838.